EUVIMEDEUVIMED entdecken
Open Access

RH genotypes and red cell alloimmunization rates in chronically transfused patients with sickle cell disease: A multisite study in the USA

Narek Israelyan iD, Sunitha Vege iD, David F Friedman iD, Zhe Zhang iD, Stacey Uter, Ross M Fasano iD, Marianne Yee iD, Connie Piccone, Shannon Kelly, Jane S Hankins iD, Yan Zheng iD, Connie M Westhoff iD und 1 weitere

Transfusion · 2024-03 · 64 (3) · 526-535

DOI: 10.1111/trf.17740 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfusion, online erschienen am 30.01.2024. Verfasst von Narek Israelyan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Blood Group Antigens, Anemia, Hemolytic, Autoimmune. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, Doris Duke Charitable Foundation, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Red cell alloimmunization remains a challenge for individuals with sickle cell disease (SCD) and contributes to increased risk of hemolytic transfusion reactions and associated comorbidities. Despite prophylactic serological matching for ABO, Rh, and K, red cell alloimmunization persists, in part, due to a high frequency of variant RH alleles in patients with SCD and Black blood donors. Study Design and Methods We compared RH genotypes and rates of alloimmunization in 342 pediatric and young adult patients with SCD on chronic transfusion therapy exposed to >90,000 red cell units at five sites across the USA. Genotyping was performed with RHD and RHCE BeadChip arrays and targeted assays.

Results

Prevalence of overall and Rh‐specific alloimmunization varied among institutions, ranging from 5% to 41% ( p = .0035) and 5%–33% ( p = .0002), respectively. RH genotyping demonstrated that 33% RHD and 57% RHCE alleles were variant in this cohort. Patients with RHCE alleles encoding partial e antigens had higher rates of anti‐e identified than those encoding at least one conventional e antigen ( p = .0007). There was no difference in anti‐D, anti‐C, or anti‐E formation among patients with predicted partial or altered antigen expression compared to those with conventional antigens, suggesting that variant Rh on donor cells may also stimulate alloimmunization to these antigens.

Discussion

These results highlight variability in alloimmunization rates and suggest that a molecular approach to Rh antigen matching may be necessary for optimal prevention of alloimmunization given the high prevalence of variant RH alleles among both patients and Black donors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellBlood Group AntigensAnemia, Hemolytic, AutoimmuneYoung AdultHumansChildErythrocyte TransfusionErythrocytesGenotypeIsoantibodiesRh-Hr Blood-Group System

Stichwörter der Autor:innen

Rh blood group systemalloimmunizationblood group genomicsimmunohematology (RBC serology, blood groups)sickle cell disease

Substanzen

Blood Group AntigensIsoantibodiesRh-Hr Blood-Group System

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Immunohematology and Genomics Laboratory, New York Blood Center Enterprise, Long Island City, New York, USA.
  • Division of Hematology, Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Division of Transfusion Medicine, Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Biomedical Informatics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Center for Transfusion Medicine and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.

ORCID-Profile: Narek Israelyan, Sunitha Vege, David F Friedman, Zhe Zhang, Ross M Fasano, Marianne Yee, Jane S Hankins, Yan Zheng, Connie M Westhoff, Stella T Chou

Förderung

  • NHLBI NIH HHS
  • Doris Duke Charitable Foundation
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Israelyan, N., Vege, S., Friedman, D. F., Zhang, Z., Uter, S., Fasano, R. M., Yee, M., Piccone, C., Kelly, S., Hankins, J. S., Zheng, Y., Westhoff, C. M., & Chou, S. T. (2024). RH genotypes and red cell alloimmunization rates in chronically transfused patients with sickle cell disease: A multisite study in the USA. Transfusion, 64(3), 526-535. https://doi.org/10.1111/trf.17740

Vancouver

Israelyan N, Vege S, Friedman DF, Zhang Z, Uter S, Fasano RM, et al. RH genotypes and red cell alloimmunization rates in chronically transfused patients with sickle cell disease: A multisite study in the USA. Transfusion. 2024;64(3):526-535. doi:10.1111/trf.17740

BibTeX
@article{Israelyan2024,
  author = {Israelyan, Narek and Vege, Sunitha and Friedman, David F and Zhang, Zhe and Uter, Stacey and Fasano, Ross M and Yee, Marianne and Piccone, Connie and Kelly, Shannon and Hankins, Jane S and Zheng, Yan and Westhoff, Connie M and Chou, Stella T},
  title = {RH genotypes and red cell alloimmunization rates in chronically transfused patients with sickle cell disease: A multisite study in the USA},
  journal = {Transfusion},
  year = {2024},
  volume = {64},
  number = {3},
  pages = {526--535},
  doi = {10.1111/trf.17740}
}
Kostenlos starten →